Innovation Pharmaceuticals Inc.
IPIX
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 521.00K | 280.00K | 318.00K | 366.00K | 513.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 802.00K | 583.00K | 641.00K | 333.00K | 1.38M |
| Operating Income | -802.00K | -583.00K | -641.00K | -333.00K | -1.38M |
| Income Before Tax | -880.00K | -681.00K | -698.00K | -361.00K | -1.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -880.00K | -681.00K | -698.00K | -361.00K | -1.43M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -880.00K | -681.00K | -698.00K | -361.00K | -1.43M |
| EBIT | -802.00K | -583.00K | -641.00K | -333.00K | -1.38M |
| EBITDA | -708.00K | -490.00K | -548.00K | -239.00K | -1.29M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 518.35M | 518.30M | 496.94M | 503.84M | 503.96M |
| Average Diluted Shares Outstanding | 518.35M | 518.30M | 496.94M | 503.84M | 503.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -2.35% | 0.00% | -8.86% | -2.66% |